Trials / Conditions / Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8
Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8
4 registered clinical trials studyying Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8 — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Prospective, US-based Study Assessing Mogamulizumab-associated Rash in Patients Diagnosed With Mycosis Fungo NCT07003100 | City of Hope Medical Center | — |
| Recruiting | Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma NCT04930653 | City of Hope Medical Center | Phase 2 |
| Active Not Recruiting | Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome NCT04652960 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Pembrolizumab in Treating Patients With Stage IB-IV Mycosis Fungoides NCT03695471 | Mayo Clinic | Phase 2 |